GLRX and cancer: After exposure of these cells to Interleukin-1 beta (IL-1β, a pleiotropic cancer-inflammation-linked cytokine), an increase in Grx1 was reported, causing a decrease in the levels of ROS and conferring to oral squamous cell carcinoma, invasiveness and migration [189].